Hong Kong’s ‘Conscience’ Prepares to Leave the Stage
David Webb has continued fighting for fairer markets and better-run companies in Hong Kong, despite growing political restrictions and his own illness.
Paul G. Clifford on How China Made it Easier to Move Things Around
The business strategist and historian of modern China talks about robots in Chinese warehouses and fixing broken links.
Chagee’s Last-Gasp Listing
Tea chain Chagee listed on the Nasdaq as calls mount to bar Chinese stocks from the U.S. markets.
The Vapor Trail
Chinese vape makers exploited a loophole in rules set during the first Trump administration to spread their products across America. Could the president's trade war...
Wall Street’s CATL Dilemma
The battery giant’s Hong Kong IPO has put big American banks in Washington’s crosshairs.
Beijing’s Port Predicament
The Chinese government risks sending a harmful message about Hong Kong companies’ independence amid the row over the future of the Panama Canal’s ports.
Grading Day
2025 has arrived. Has China’s grand vision for tech supremacy lived up to the hype?
The Trump Tariff Challenge for Multinational Companies
With the U.S. emulating China’s protectionism, global firms face tricky decisions over where to invest.
U.S.-China Drugs Tie-ups Come Under Threat
A surge in dealmaking that's helped Chinese biotech and healthcare firms sell their products globally faces several headwinds.
Intel’s Surprising Savior
From the Archive: The new leader of America’s chip champion is a prolific and longtime investor in China’s semiconductor industry.
Beijing’s Uranium Edge
China has the upper hand in the battle for nuclear fuel but is on the hunt for more.
China’s Tech Giants Look to Healthcare
Big tech companies see an opportunity in healthcare but making their businesses profitable has been a challenge to date.